Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023
08.03.2023 - BEDMINSTER, N.J., March 08, 2023 (GLOBE NEWSWIRE) - Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its ...
Jody Cain Matinas Biopharma National Resilience Inc About Matinas Private Securities Litigation Reform Act National Resilience
Source: wallstreet-online.de